Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jun Inoue

Jun Inoue, Osaka City JP

Patent application numberDescriptionPublished
20090255768BICYCLE SUSPENSION HAVING STROKE AND DAMPER ADJUSTMENT - A bicycle suspension including a stroke adjustment unit, a suspension damper, and a damper adjustment unit. The stroke adjustment unit is configured to adjust a stroke of the bicycle suspension, which is configured to expand and contract within the stroke. The suspension damper is configured to apply damping force to the bicycle suspension, and the damper adjustment unit is configured to adjust the damping force applied by the suspension damper in accordance with the stroke adjusted by the stroke adjustment unit.10-15-2009
20110084464ADJUSTABLE BICYCLE SUSPENSION SYSTEM - An adjustable bicycle suspension system includes a first stroke adjustment unit and a second stroke adjustment unit. The first stroke adjustment unit is configured to adjust a stroke of a suspension by changing a position of the suspension at a first position or a second position. The second stroke adjustment unit is configured to change the position of the suspension at the second position independently from the first position.04-14-2011

Jun Inoue, Osaka JP

Patent application numberDescriptionPublished
20090072613BICYCLE WHEEL SECURING STRUCTURE - A bicycle wheel securing structure includes a bicycle fork, an adapter and a holding member. The bicycle fork has two axle support portions that are spaced apart for receiving a bicycle hub therebetween. The adapter is disposed in an adapter receiving bore in one of the axle support portions. The adapter includes a threaded axle mounting opening. The holding member is operatively coupled between the adapter and the one of the axle support portions with the adapter. The holding member prevents both rotational movement of the adapter with respect to the bicycle fork and axial movement of the adapter with respect to the bicycle fork along an axis of the axle mounting opening when the holding member is in a retaining position. The adapter is rotatable within the adapter receiving bore without moving axially with respect to the bicycle fork when the holding member is in a releasing position.03-19-2009
20100025957BICYCLE SUSPENSION SYSTEM - A bicycle suspension system is provided with a first tubular element, a piston, a piston rod, a first sealing member and a switching valve. The piston is coupled to the piston rod, and is slidably disposed in the first tubular element. The first sealing member is disposed in the first tubular element adjacent such that a first air chamber is formed between the piston and the first sealing member. The switching valve is coupled to the first sealing member. The switching valve opens a communication passageway between the first air chamber and a second air chamber to connect the first and second air chambers when in the opened position, and closes the communication passageway between the first air chamber and the second air chamber to separate the first and second air chambers when in the closed position.02-04-2010
20110079984BICYCLE WHEEL SECURING STRUCTURE - A bicycle wheel securing structure includes a bicycle fork, an adapter and a holding member. The bicycle fork has two axle support portions that are spaced apart for receiving a bicycle hub therebetween. The adapter is disposed in an adapter receiving bore in one of the axle support portions. The adapter includes a threaded axle mounting opening. The holding member is operatively coupled between the adapter and the one of the axle support portions with the adapter. The holding member prevents both rotational movement of the adapter with respect to the bicycle fork and axial movement of the adapter with respect to the bicycle fork along an axis of the axle mounting opening when the holding member is in a retaining position. The adapter is rotatable within the adapter receiving bore without moving axially with respect to the bicycle fork when the holding member is in a releasing position.04-07-2011

Patent applications by Jun Inoue, Osaka JP

Jun Inoue, Hyogo JP

Patent application numberDescriptionPublished
20090306111Pharmaceutical Comprising PPAR Agonist - An object of the present invention is to provide an agent for promoting proliferation of a meibomian gland epithelial cell and a corneal epithelial cell, as well as provide an agent for treating an ocular disease such as meibomian gland dysfunction or evaporative dry eye.12-10-2009
20100190833PHARMACEUTICAL CONTAINING PPARA AGONIST - Provision of an agent for promoting proliferation of meibomian gland epithelial cells or corneal epithelial cells, and a therapeutic agent for ocular diseases such as meibomian gland dysfunction, dry eye and the like.07-29-2010

Patent applications by Jun Inoue, Hyogo JP

Jun Inoue, Tokyo JP

Patent application numberDescriptionPublished
20080312093Method for detecting cancer and a method for suppressing cancer - An object of the invention is to find a cancer-associated gene to be used as an index for detecting canceration of cells and degree of malignancy of cancer, so as to provide a method for detecting cancer using the cancer-associated gene as an index and provide a method of suppressing/treating cancer using the cancer-associated gene as essential part. According to the present invention, specific genes which are amplified or deleted in gastric carcinoma as compared with normal cell have been collectively found, and a method for detecting cancer using amplification or deletion of these cancer-associated genes as an index is provided. Further, cancer can be suppressed by introducing a gene which is deleted in cancer cells among these cancer-associated genes into cancer and inhibiting the transcription product of the gene amplified.12-18-2008
20090011424Cancer-suppressing agents - It is an object of the present invention to provide a cancer-suppressing agent comprising a novel cancer-suppressing gene based on the discovery of such cancer-suppressing gene. The present invention provides a cancer-suppressing agent which comprises NR1I2 gene or a homologous gene thereof; and a cancer-suppressing agent which comprises NR1I2 protein or a homologous protein thereof.01-08-2009
20090074849Cancer-suppressing agents - It is an object of the present invention to provide a cancer-suppressing agent comprising a novel cancer-suppressing gene based on the discovery of such cancer-suppressing gene. The present invention provides a cancer-suppressing agent which comprises NR1I2 gene or a homologous gene thereof; and a cancer-suppressing agent which comprises NR1I2 protein or a homologous protein thereof.03-19-2009
20100105868METHOD FOR DETECTING NEUROBLASTOMA - The present invention is intended to provide a means for judging the malignancy of neuroblastoma and the progress of spontaneous regression thereof. The present invention provides a method for detecting cancer which comprises detecting activation or inactivation of the lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) gene and amplification of the MYCN gene in a specimens to evaluate the malignancy of the specimens and the progress of spontaneous regression.04-29-2010

Patent applications by Jun Inoue, Tokyo JP

Jun Inoue, Nishikasugai-Gun JP

Patent application numberDescriptionPublished
20090070982METHOD OF PREPARING HONEYCOMB SEGMENT JOINED BODY - There is disclosed a method for preparing a honeycomb segment joined body in which a plurality of honeycomb segments are arranged in directions parallel to a first flat surface and a second flat surface of an installation reference jig to install the honeycomb segments in predetermined positions via a paste-like joining material on the installation reference jig by use of the installation reference jig having the first flat surface and the second flat surface forming a right angle therebetween, and then the joining material is dried and cured to join the plurality of honeycomb segments together. In the preparation method, in at least a part of a process of successively installing the plurality of honeycomb segments in the predetermined positions, when a new honeycomb segment is installed, at least a part of the installed honeycomb segments is pressurized and held in the predetermined positions so that the already installed honeycomb segments are not displaced.03-19-2009
20090237652APPARATUS FOR INSPECTING DEFECTS OF HONEYCOMB STRUCTURE - According to an apparatus for inspecting defects of a honeycomb structure that is provided with a current plate and an air current formation means (air source and a header tube), fine defects or defects taking place in the vicinity of an outer periphery of the honeycomb structure can be detected with high sensitivity.09-24-2009

Jun Inoue, Kobe-Shi JP

Patent application numberDescriptionPublished
20090118322Agent for repairing corneal sensitivity containing amide compound - The amide compound of the formula (I) [each symbol is as defined in the description] has a promoting action on neuritogenesis of trigeminal nerve cells, and the compound is useful as a corneal neuritogenesis promoter, an agent for recovering corneal sensitivity by promotion of corneal neuritogenesis, and an agent for treating dry eye.05-07-2009

Patent applications by Jun Inoue, Kobe-Shi JP

Jun Inoue, Shizuoka JP

Patent application numberDescriptionPublished
20110178299OPTICALLY ACTIVE DIFLUOROMETHANESULFONANILIDE DERIVATIVE AND HERBICIDE - The present invention aims at providing an optically active difluoromethanesulfonanilide derivative exhibiting an excellent herbicidal activity at a low dose.07-21-2011

Jun Inoue, Woodland Hills, CA US

Patent application numberDescriptionPublished
20110275617OPHTHALMIC COMPOSITION - The present invention provides an ophthalmic composition comprising a hyperbranched polymer. The ophthalmic compositions may also comprise carbonic anhydrase inhibitors, wherein the hyperbranched polymer increases the aqueous solubility of the carbonic anhydrase inhibitor, and increases corneal permeation of the active agent. The ophthalmic compositions may also comprise non-ionic surfactants, such as polysorbate, hydroxypropyl methyl cellulose or hydroxyethyl cellulose, and beta-blockers, such as carteolol, levobunolol, betaxolol, metipranolol, timolol or propranolol.11-10-2011